Literature DB >> 23878780

Biomechanical characteristics of bone in streptozotocin-induced diabetic rats: An in-vivo randomized controlled experimental study.

Nektarios Korres1, Eleftherios Tsiridis, George Pavlou, Athanasios Mitsoudis, Despina N Perrea, Aristedes B Zoumbos.   

Abstract

AIM: To investigate the in vivo effects of type I diabetes on the mechanical strength of tibial bone in a rodent model.
METHODS: The biomechanical effect of diabetes on the structural integrity of the tibia in streptozotocin induced diabetic Wistar rats was analysed. Induction of diabetes was achieved by an intra-peritoneal injection and confirmed by measuring serial blood glucose levels (> 150 mg/dL). After 8 wk the tibiae were harvested and compared to a control group. Biomechanical analysis of harvested tibiae was performed using a three-point bending technique on a servo hydraulic MTS 858 MiniBionix frame. Maximum force applied to failure (N), stiffness (N × mm) and energy absorbed (N/mm) were recorded and plotted on load displacement curves. A displacement control loading mode of 1 mm/min was selected to simulate quasi-static loading conditions. Measurements from load-displacement curves were directly compared between groups.
RESULTS: Fourteen streptozotocin induced diabetic Wistar rats were compared against nineteen non-diabetic controls. An average increase of 155.2 g in body weight was observed in the control group compared with only 5 g in the diabetic group during the experimental study period. Levels of blood glucose increased to 440.25 mg/dL in the diabetic group compared to 116.62 mg/dL in the control group.The biomechanical results demonstrate a highly significant reduction in the maximum load to failure from 69.5 N to 58 N in diabetic group compared to control (P = 0.011). Energy absorption to fracture was reduced from 28.2 N in the control group to 23.5 N in the diabetic group (P = 0.082). No significant differences were observed between the groups for bending stiffness.
CONCLUSION: Streptozotocin-induced diabetes in rodents reduces the maximum force and energy absorption to failure of bone, suggesting a predisposition for fracture risk.

Entities:  

Keywords:  Biomechanics; Bone; Rodent; Streptozotocin

Year:  2013        PMID: 23878780      PMCID: PMC3717245          DOI: 10.5312/wjo.v4.i3.124

Source DB:  PubMed          Journal:  World J Orthop        ISSN: 2218-5836


  23 in total

1.  Influence of nonenzymatic glycation on biomechanical properties of cortical bone.

Authors:  D Vashishth; G J Gibson; J I Khoury; M B Schaffler; J Kimura; D P Fyhrie
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

2.  Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats.

Authors:  Nurten Erdal; Serkan Gürgül; Servet Kavak; Altan Yildiz; Mustafa Emre
Journal:  Biol Trace Elem Res       Date:  2010-05-06       Impact factor: 3.738

3.  Nucleoside and ribonucleic acid metabolism in isolated bone cells. Effects of insulin and cortisol in vitro.

Authors:  W A Peck; K Messinger
Journal:  J Biol Chem       Date:  1970-05-25       Impact factor: 5.157

4.  Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106-01: an osteoblast-like cell.

Authors:  J Hickman; A McElduff
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

5.  The biomechanical integrity of bone in experimental diabetes.

Authors:  G K Reddy; L Stehno-Bittel; S Hamade; C S Enwemeka
Journal:  Diabetes Res Clin Pract       Date:  2001-10       Impact factor: 5.602

6.  Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells.

Authors:  J R Levy; E Murray; S Manolagas; J M Olefsky
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

7.  Effect of diabetes mellitus on the material properties of the distal tibia.

Authors:  John G Fleischli; Terese J Laughlin; Kyriacos Athanasiou; Dan R Lanctot; Lawrence Lavery; Xiaodu Wang; C Mauli Agrawal
Journal:  J Am Podiatr Med Assoc       Date:  2006 Mar-Apr

8.  Effects on the bones of vanadyl acetylacetonate by oral administration: a comparison study in diabetic rats.

Authors:  Shuang-Qing Zhang; Guo-Hua Chen; Wan-Liang Lu; Qiang Zhang
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

9.  Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life.

Authors:  Matthew J Silva; Michael D Brodt; Michelle A Lynch; Jennifer A McKenzie; Kristi M Tanouye; Jeffry S Nyman; Xiaodu Wang
Journal:  J Bone Miner Res       Date:  2009-09       Impact factor: 6.741

10.  Defects of early fracture-healing in experimental diabetes.

Authors:  L R Macey; S M Kana; S Jingushi; R M Terek; J Borretos; M E Bolander
Journal:  J Bone Joint Surg Am       Date:  1989-06       Impact factor: 5.284

View more
  7 in total

1.  Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.

Authors:  Dongye Zhang; Minyi Hu; Timothy Chu; Liangjun Lin; Jingyu Wang; Xiaodong Li; Hua Zhu Ke; Yi-Xian Qin
Journal:  Bone       Date:  2016-02-08       Impact factor: 4.398

2.  High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes in Rats Impacts Osteogenesis and Wnt Signaling in Bone Marrow Stromal Cells.

Authors:  Chao Qian; Chenyuan Zhu; Weiqiang Yu; Xinquan Jiang; Fuqiang Zhang
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

3.  Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats.

Authors:  Raul Hernandes Bortolin; Bento João da Graça Azevedo Abreu; Marcela Abbott Galvão Ururahy; Karla Simone Costa de Souza; João Felipe Bezerra; Melina Bezerra Loureiro; Flávio Santos da Silva; Dáfiny Emanuele da Silva Marques; Angélica Amanda de Sousa Batista; Gisele Oliveira; André Ducati Luchessi; Valéria Morgiana Gualberto Duarte Moreira Lima; Carlos Eduardo Saraiva Miranda; Marcus Vinicius Lia Fook; Maria das Graças Almeida; Luciana Augusto de Rezende; Adriana Augusto de Rezende
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot Study.

Authors:  Luke Watson; Xi Zhe Chen; Aideen E Ryan; Áine Fleming; Aoife Carbin; Lisa O'Flynn; Paul G Loftus; Emma Horan; David Connolly; Patrick McDonnell; Laoise M McNamara; Timothy O'Brien; Cynthia M Coleman
Journal:  Cells       Date:  2020-06-03       Impact factor: 6.600

Review 5.  Impact of Diabetes Mellitus on Bone Health.

Authors:  Cliodhna E Murray; Cynthia M Coleman
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

6.  Vibration therapy as an effective approach to improve bone healing in diabetic rats.

Authors:  Maysa S Campos; José B Volpon; João Paulo B Ximenez; Ana Paula Franttini; Christopher E Dalloul; Manoel D Sousa-Neto; Raquel A Silva; Melissa A Kacena; Ariane Zamarioli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

7.  Influence of hyperbaric oxygen on biomechanics and structural bone matrix in type 1 diabetes mellitus rats.

Authors:  Pedro Henrique Justino Oliveira Limirio; Huberth Alexandre da Rocha Junior; Richarlisson Borges de Morais; Karen Renata Nakamura Hiraki; Ana Paula Coelho Balbi; Priscilla Barbosa Ferreira Soares; Paula Dechichi
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.